Turgay Ulaş

ORCID: 0000-0001-9332-663X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Peptidase Inhibition and Analysis
  • Hematopoietic Stem Cell Transplantation
  • Platelet Disorders and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Cutaneous lymphoproliferative disorders research
  • Blood groups and transfusion
  • Eosinophilic Esophagitis
  • Helicobacter pylori-related gastroenterology studies
  • Protein Degradation and Inhibitors
  • Acute Myeloid Leukemia Research
  • Complement system in diseases
  • Gout, Hyperuricemia, Uric Acid
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Parasitic infections in humans and animals
  • Congenital Anomalies and Fetal Surgery
  • CAR-T cell therapy research
  • Acute Myocardial Infarction Research
  • COVID-19 Clinical Research Studies
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac electrophysiology and arrhythmias
  • Liver Disease and Transplantation
  • Coronary Interventions and Diagnostics

Sağlık Bilimleri Üniversitesi
2024-2025

Ministry of Health
2024-2025

German Center for Neurodegenerative Diseases
2025

University of Health Science
2025

Ankara Onkoloji Eğitim ve Araştırma Hastanesi
2011-2024

Near East University
2018-2023

Mersin Üniversitesi
2023

Akdeniz University
2014-2022

State Hospital
2012-2020

Marmara University
2020

In this study, we aimed to compare the engraftment days, graft-versus-host disease (GVHD) development, relapse and overall survival rates in patients using myeloablative/reduced intensity conditioning regimens with posttransplant cyclophosphamide (PTCy) 25 mg/kg x2 Anti-T lymphocyte Globulin (ATLG) (n = 29) PTCy 50 doses 41) acute leukemias. Matched related, matched unrelated, 1 mismatched haploidentical donors were selected for patients. Platelet (median 11 vs 17 days) neutrophil 14 15...

10.1038/s41409-025-02564-8 article EN cc-by-nc-nd Bone Marrow Transplantation 2025-04-13

Background: Extranodal natural killer/T-cell lymphoma, nasal type (ENKL), or NK/T-cell lymphoma is the most common cause of syndrome known as “fatal midline granuloma.” Aim: In this study, we aimed to analyze treatment outcomes extranodal killer (NK)/T-cell lymphomas. Methods: Data 39 patients from 15 centers were evaluated retrospectively. The characteristics that determine risk status patients, in which treatments they received, and their responses observed. Results: Complete response was...

10.4103/njcp.njcp_499_24 article EN Nigerian Journal of Clinical Practice 2025-05-01

Background and Aim: Breast cancer is the most common type of amongst women today. The aim this study was to examine association between complementary alternative medicine (CAM) quality life (QoL), anxiety depression demographic characteristics with breast cancer. Materials Methods: QoL measured by European Organization for Treatment Research Cancer core questionnaire (QLQ-C30, version 3.0) hospital scale. Results: In total, 122 patients were enrolled in 50% (n = 61) them reported that they...

10.4103/0973-1482.138010 article EN Journal of Cancer Research and Therapeutics 2014-01-01

Resistive index (RI) is an indirect measurement of blood flow resistance that can be used to evaluate vascular damage.The purpose this study the association between RI values orbital and intrarenal arteries by means Doppler ultrasonography (US).We evaluated 103 diabetic patients. As a control group, 30 subjects were examined. The patients divided into two groups. Group 1 consisted with urinary albumin excretion (UAE) <300 mg/day estimated glomerular filtration rate (eGFR) levels >90 ml/min...

10.1159/000336105 article EN Kidney & Blood Pressure Research 2012-01-01

The objective of the study was to examine quality life amongst end stage renal disease (ESRD) haemodialysis patients in Malaysia.A cross sectional descriptive conducted on 72 ESRD at a Dialysis Centre Malaysia. modified KDQOL-SF™ subscales, kidney disease-targeted scale and 36 item health survey questionnaires were used.The overall rating 66.73 ± 11.670 indicating good life. There no significant difference between for different domains according gender (p >0.05). However, there differences...

10.7417/ct.2013.1627 article EN PubMed 2013-01-01

Objective: In this experimental study, we investigated the possible effects of intracameral moxifloxacin on oxidative stress parameters and endothelial cell morphology in corneal tissue.Methods: total, 30 rats were randomly assigned to three groups 10 rats: sham group (Group 1, n = 10); control 2), where balanced salt solution (BSS) was administered at a dose 0.01 cc (n treatment 3), 0.05 mg/0.01 10). Total antioxidant status (TAS) total oxidant (TOS) tissue blood samples measured index...

10.3109/15569527.2014.918138 article EN Cutaneous and Ocular Toxicology 2014-06-25

The prognosis is poor for relapsed or refractory (R/R) classical Hodgkin Lymphoma (cHL) patients. brentuximab vedotin (Bv) and bendamustine (B) combination has been used as a preferable salvage regimen in R/R cHL patient trials. We retrospectively evaluated response rates, toxicities, the survival patients treated with BvB combination. In multi-centre real-life study, 61 HL received intravenous doses of 1.8 mg/kg Bv on first day plus 90 mg/m2 B second days 21-day cycle second-line...

10.1080/1120009x.2021.1976912 article EN Journal of Chemotherapy 2021-09-13

A multicenter, retrospective, observational study was conducted to explore effectiveness and safety of ixazomib plus lenalidomide with dexamethasone (IRd) in relapsed/refractory multiple myeloma (RRMM) patients following at least ≥ two lines therapy. Patients' treatment responses, overall response rate, progression-free survival adverse events were recorded. Mean age 54 66.5 ± 9.1 years. There 20 (37.0%) progression. Median 13 months who received a median three therapy 7.5-month follow-up...

10.1080/1120009x.2023.2208439 article EN Journal of Chemotherapy 2023-05-21

RS3PE (remitting seronegative, symmetric synovitis with pitting edema) is a benign, seronegative syndrome, an acute onset of edema on the dorsum both hands and feet, which affects predominantly peripheral joints such as wrists ankles symmetrically. A 58-year-old man presented symmetrical polysynovitis associated feet. He responded well to low-dose corticosteroids. There was no evidence erosion radiologically. The clinical manifestations patient were consistent syndrome. Here, we present case...

10.5152/tjr.2010.08 article EN cc-by-nc Turkish Journal of Rheumatology 2010-05-07
Coming Soon ...